BYDUREON Monotherapy versus Metformin, Sitagliptin, and Pioglitazone A 26-week, randomized, comparator-controlled trial was conducted to compare the safety and efficacy of BYDUREON to metformin, sitagliptin, and pioglitazone in patients with type 2 diabetes whose glycemic control was inadequate with diet and exercise (Trial 3 - NCT00676338)
Continue using the program: Use the card every time you fill your prescription for Ozempic
Interestingly, in a group of seven vegans/vegetarians given 500 mg/day of supplemental L-carnitine for two to three months, only three demonstrated increased GBB-to-TMA conversion.6 There could be a genetic explanation
longevity-
New Evidence on Cancer Progression and Survival Perhaps the most intriguing findings have emerged from recent oncology research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
When initiating WEGOVY, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions (5.4), Adverse Reactions (6.1)]
